ReviewFrontiers in immunology2026

Chimeric antigen receptor T-cell therapy for rheumatic diseases: from B-cell depletion to immune reset and beyond.

Yiqing Zhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.